Medical Cannabis Dosage Forms – Diversity, Evidence and Regulatory Perspectives

Cannabis Flower and Extracts: The Core of Treatment 

Since 2017, most medical cannabis prescriptions in Germany have been based on cannabis flower and pharmacy-compounded preparations. (In individual cases, access was already possible before 2017 through special exemptions.) Cannabis flower is typically ground and inhaled using medical vaporizers. This allows for a fast onset of effects and flexible dosing. While it is a plant-based product, quality and consistency are tightly regulated. European Pharmacopoeia standards, for example, define acceptable ranges for active ingredients. 

Oral Administration: Oils, Extracts and Distillates 

Oral products are an important part of treatment, especially where a longer-lasting effect is needed. These include oil-based solutions, standardized extracts and highly purified distillates, usually taken as drops, capsules or oral sprays. 

Oil-based products, often containing dronabinol, can be dosed drop by drop. This makes them particularly useful when starting or adjusting treatment. Distillates are highly purified and contain a single cannabinoid at high concentration, allowing very precise dosing. 

Standardized extracts sit between these two approaches. They contain a defined mix of cannabinoids, offering consistency while still reflecting part of the plant’s natural profile. 

Approved Cannabis-Based Medicines 

In addition to compounded preparations, a small number of cannabis-based medicines are approved in Germany. These include THC-based products such as Canemes and combined THC and CBD products such as Sativex. Topical applications such as creams and ointments are also used in certain cases. 

These medicines follow the standard drug approval pathway, with clearly defined indications and clinical evidence. In practice, their use is more limited than that of individualized cannabis therapies. 

Cannabis-based treatments range from isolated active substances to full-spectrum plant products. Single-compound medicines allow for precise dosing and clear pharmacology. At the same time, the cannabis plant offers a wide range of cannabinoids, terpenes and flavonoids. Their interaction, often referred to as the entourage effect, influences the therapeutic outcome. 

What’s Next: New Dosage Forms  

As the medical cannabis market continues to evolve, additional dosage forms are gaining attention in Germany. These include inhalation systems with standardized cartridges as well as new oral products with predefined doses, often referred to as gummies. 

Cartridge-based inhalation systems are used with vaporizers that are certified under the EU Medical Device Regulation (MDR). The cartridges can be filled with suitable cannabis extracts in the pharmacy before being dispensed to patients. These developments reflect a broader trend. Patients are looking for options that are simple, consistent and easy to integrate into daily life. This is particularly relevant for people with limited fine motor skills, for example those with tremor or neurological conditions. 

Conclusion 

For medical care, the key takeaway is clear: a broader range of dosage forms allows therapies to be tailored more precisely to individual patient needs and medical conditions. 

At the same time, the evolution of dosage forms highlights how dynamic the global medical cannabis field has become. For Germany, the key challenge will be to accommodate innovation while maintaining clear regulatory standards that ensure safety, quality and reliable patient care. 

Anything else?

Do you have specific questions or suggestions for the Cannabis Briefing? Then send us an email to briefing@www.cansativa.de. If you are interested in revolutionising the cannabis industry with us, then stay tuned and follow our briefings!

We wish you a good read!

Best wishes from both of us,